NGM(Delisted)
Ngm BiopharmaceuticalsยทNASDAQ
--
--(--)
NGM Profile
Ngm Biopharmaceuticals, Inc.
A company that developing therapeutics for cardio-metabolic, liver, oncologic, and ophthalmic diseases
333 Oyster Point Boulevard, South San Francisco, California 94080
--
Ngm Biopharmaceuticals, Inc., was incorporated in Delaware on December 20, 2007. The company is a biopharmaceutical company focused on the discovery and development of new, potentially life-changing drugs, based on a scientific understanding of the key biological pathways behind serious diseases with serious unmet or underserved patient needs. Since commencing operations in 2008, the company has produced a range of product candidates from early discovery to Phase 2b development. Currently, the company has five projects in clinical development.
